Stocks
Tekla Life Sciences InvestorsHQL
NYSEHealthcareBiotechnology$16.37-1.50%
A closed-end management investment company focused on life sciences and healthcare investments, Tekla Life Sciences Investors provides capital appreciation through a diversified portfolio of biotech, pharmaceutical, and medical device companies. The fund is managed by Tekla Capital Management, which specializes in healthcare sector investments. Investors track it for exposure to high-growth potential in the life sciences industry.
Market Cap: $472.6M52W Range: $10.55 – $17.80
Congressional Interest in Tekla Life Sciences Investors (HQL)
2 members of Congress have disclosed 7 trades in Tekla Life Sciences Investors (HQL), a Healthcare company. The buy/sell breakdown shows 4 purchases versus 3 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
7
Unique Politicians
2
Buys
4
Sells
3
Who in Congress Is Trading HQL?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2022-10-04 | Thomas R Carper | sell | $1K – $15K |
| 2020-02-22 | Thomas R Carper | buy | $1K – $15K |